Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Graham Packham

Showing results (1-10 of 128) with videos related to

Pageof 13
Sort By:
Apoptosis : an International Journal on Programmed Cell Death|May 27, 2003
Mechanisms of cell death and disease: advances in therapeutic interventionGraham Packham
British Journal of Haematology|June 25, 2008
The role of NF-kappaB in lymphoid malignanciesGraham Packham
Seminars in Cancer Biology|September 7, 2010
The role of the B-cell receptor in the pathogenesis of chronic lymphocytic leukaemiaGraham Packham, Freda Stevenson
Exploration of Targeted Anti-Tumor Therapy|September 1, 2022
Exploration of Targeted Anti-tumor Therapy: a contribution to the development of targeted therapiesNicola Normanno, Graham Packham
British Journal of Haematology|June 26, 2003
Regulation of tumour necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced apoptosis in Burkitt's lymphoma cell linesAmalia Mouzakiti, Graham Packham
Blood|February 20, 2016
Shooting the messenger (RNA) in B-cell lymphomaAlison Yeomans, Graham Packham
Methods in Molecular Medicine|July 7, 2005
Purification of primary malignant B-cells and immunoblot analysis of bcl-2 family proteinsClaire Dallman, Graham Packham
Immunology|April 5, 2005
Bodyguards and assassins: Bcl-2 family proteins and apoptosis control in chronic lymphocytic leukaemiaGraham Packham, Freda K Stevenson
Expert Opinion on Investigational Drugs|May 27, 2014
Investigational epigenetically targeted drugs in early phase trials for the treatment of haematological malignanciesJessica Okosun, Graham Packham, Jude Fitzgibbon
The Journal of Organic Chemistry|November 11, 2008
Macrolactamization versus macrolactonization: total synthesis of FK228, the depsipeptide histone deacetylase inhibitorShijun Wen, Graham Packham, A Ganesan
Pageof 13

Showing results (1-10 of 128) with videos related to

Sort By:
Pageof 13
Apoptosis : an International Journal on Programmed Cell Death|May 27, 2003
Mechanisms of cell death and disease: advances in therapeutic interventionGraham Packham
British Journal of Haematology|June 25, 2008
The role of NF-kappaB in lymphoid malignanciesGraham Packham
Seminars in Cancer Biology|September 7, 2010
The role of the B-cell receptor in the pathogenesis of chronic lymphocytic leukaemiaGraham Packham, Freda Stevenson
Exploration of Targeted Anti-Tumor Therapy|September 1, 2022
Exploration of Targeted Anti-tumor Therapy: a contribution to the development of targeted therapiesNicola Normanno, Graham Packham
British Journal of Haematology|June 26, 2003
Regulation of tumour necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced apoptosis in Burkitt's lymphoma cell linesAmalia Mouzakiti, Graham Packham
Blood|February 20, 2016
Shooting the messenger (RNA) in B-cell lymphomaAlison Yeomans, Graham Packham
Methods in Molecular Medicine|July 7, 2005
Purification of primary malignant B-cells and immunoblot analysis of bcl-2 family proteinsClaire Dallman, Graham Packham
Immunology|April 5, 2005
Bodyguards and assassins: Bcl-2 family proteins and apoptosis control in chronic lymphocytic leukaemiaGraham Packham, Freda K Stevenson
Expert Opinion on Investigational Drugs|May 27, 2014
Investigational epigenetically targeted drugs in early phase trials for the treatment of haematological malignanciesJessica Okosun, Graham Packham, Jude Fitzgibbon
The Journal of Organic Chemistry|November 11, 2008
Macrolactamization versus macrolactonization: total synthesis of FK228, the depsipeptide histone deacetylase inhibitorShijun Wen, Graham Packham, A Ganesan
Pageof 13